US EditionPublished • loading... • Updated
Brazilian securities watchdog seeks U.S. evidence for class action lawsuit alleging ‘$690M IPO fraud’
Summary by offshorealert.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Brazilian securities watchdog seeks U.S. evidence for class action lawsuit alleging ‘$690M IPO fraud’
Brazilian non-profit ABRAICC, which ‘protects the rights and interests of investors in capital markets’, has applied to take discovery from Goldman Sachs in New York for an intended class action lawsuit in Brazil alleging securities fraud against cancer research company Oncoclínicas do Brasil Serviços Médicos S.A, which raised $690 million in a Goldman Sachs-led IPO in 2021 and whose “group of controlling shareholders” allegedly included Centaur…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
